Innate Pharma SA, the French developer of cancer treatments that operate through the innate immune system, has appointed Hemanshu Shah as Executive Vice President and Chief Business Officer at its newly formed US subsidiary, Innate Pharma Inc.
He will report to Jérôme Tiollier, previously director of Development and Operations of the parent company, who has been appointed president of the US subsidiary.
Mr Shah has worked for Johnson & Johnson, Bristol-Myers Squibb and most recently at GPC Biotech. He holds a doctorate degree in pharmaceutical sciences from Rutgers University in New Jersey.
Source
Innate Pharma press release 23 April 2008
Copyright 2008 Evernow Publishing Ltd